Professor at the Université de Montréal’s Department of Medicine and regular researcher with the CHUM Research Centre’s Cancer Research Theme, Anne-Marie Mes-Masson joined the ranks of Canada’s Most Powerful Women: Top 100 this year, in the Science and Technology category.
Presented by the Women’s Executive Network since 2003, these awards recognize the professional accomplishments of women throughout Canada.
In the early 90s, she and her collaborators set up the first ovarian cancer tumour bank. Over time, she established herself as a leader in the collection and banking of biological specimens of different types of tumours.
Recognized nationally and internationally for her key cancer research findings, Mes-Masson is an outstanding researcher and woman. This award recognizes, among other things, her commitment and vision.
“Anne-Marie Mes-Masson is without question a pioneer in translational research, mainly in the areas of ovarian and prostate cancer. With clinician-researchers and collaborators across all disciplines, she has implemented research programs that have led to the discovery of new treatments or facilitated personalized medicine approaches, while providing tangible benefits for patient health. We are very proud to have her among us here at the Research Centre,” stated Vincent Poitout, Scientific Director of the CRCHUM and Director of Research at the CHUM.
In the area of prostate cancer, for example, Mes-Masson’s research work has provided important clues about the genes that lead to the most aggressive forms of the disease.